CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway.
Liu H, Guo W, Wang T, Cao P, Zou T, Peng Y, Yan T, Liao C, Li Q, Duan Y, Han J, Zhang B, Chen Y, Zhao D, Yang X.
Liu H, et al. Among authors: cao p.
Cell Biol Toxicol. 2024 Feb 6;40(1):10. doi: 10.1007/s10565-024-09848-7.
Cell Biol Toxicol. 2024.
PMID: 38319449
Free PMC article.